Hepatitis E Vaccine Debuts Thanks to Chinese Biotech Partnership

hepatitis-e-vaccine-china

The world’s first vaccine against the hepatitis E virus began being deployed from China last week, promising to stop the propagation of a disease that infects 20 million people yearly and claims 70,000 lives. This vaccine is the result of an unusual public-private partnership in China’s biotechnology sector, and could help deliver other vaccines for diseases that have been overlooked.

Read more @ SciTechDaily